Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$173.75
-1.2%
$168.96
$134.50
$178.87
$19.39B0.78965,328 shs1.03 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.00%+6.10%+4.59%+11.83%+26.32%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4.5969 of 5 stars
2.33.04.24.73.32.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.69
Moderate Buy$183.735.75% Upside

Current Analyst Ratings Breakdown

Latest DGX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/23/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$182.00 ➝ $190.00
4/23/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$175.00 ➝ $180.00
4/23/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$175.00 ➝ $185.00
4/23/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$191.00 ➝ $194.00
4/9/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$178.00 ➝ $189.00
4/2/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$195.00
4/2/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$195.00
3/20/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$190.00 ➝ $191.00
3/4/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$185.00 ➝ $185.00
2/4/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$173.00 ➝ $180.00
(Data available from 4/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$10.16B1.91$13.55 per share12.82$61.04 per share2.85
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$871M$7.9122.5916.562.168.80%15.07%6.72%N/A

Latest DGX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/22/2025Q1 2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billion
1/30/2025Q4 2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.19$2.23+$0.04$1.95$2.58 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.201.84%+6.94%40.46%14 Years

Latest DGX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/30/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.802.06%4/7/20254/7/20254/21/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.82
1.10
1.02

Institutional Ownership

CompanyInstitutional Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%

Insider Ownership

CompanyInsider Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
8.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
49,000111.61 million110.73 millionOptionable

Recent News About These Companies

Q3 EPS Estimate for Quest Diagnostics Raised by Analyst
Leerink Partnrs Issues Negative Outlook for DGX Earnings
Leerink Partnrs Has Pessimistic Outlook of DGX Q2 Earnings
Truist Financial Keeps Their Hold Rating on Quest Diagnostics (DGX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$173.75 -2.12 (-1.21%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$173.73 -0.02 (-0.01%)
As of 04/25/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.